Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses

Journal of Immunology

Volumn 184, Issue 8, 2010, Pages 4115-4122

  Hensley, Scott E ^a   Zanker, Damien ^b   Dolan, Brian P ^a   David, Alexandre ^a   Hickman, Heather D ^a   Embry, Alan C ^a   Skon, Cara N ^a   Grebe, Kristie M ^a   Griffin, Thomas A ^c   Chen, Weisan ^b   Bennink, Jack R ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEASOME; PROTEIN LMP2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; LMP 2 PROTEIN; LMP-2 PROTEIN; PROTEIN SUBUNIT; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL SURVIVAL; DENDRITIC CELL; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CONGENIC STRAIN; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DENDRITIC CELLS; IMMUNITY, INNATE; INFLUENZA A VIRUS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; SIGNAL TRANSDUCTION;

EID: 77952770300     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903003     Document Type: Article

References (41)

1. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class molecules. Cell 78: 761-771.
2. Kisselev, A. F., T. N. Akopian, K. M. Woo, and A. L. Goldberg. 1999. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem. 274: 3363-3371.
3. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78: 773-785. (Pubitemid 24294453)
4. Hoppe, T., K. Matuschewski, M. Rape, S. Schlenker, H. D. Ulrich, and S. Jentsch. 2000. Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell 102: 577-586.
5. Löwe, J., D. Stock, B. Jap, P. Zwickl, W. Baumeister, and R. Huber. 1995. Crystal structure of the 20S proteasome from the Archaeon T. acidophilum at 3.4 A resolution. Science 268: 533-539.
6. Tanaka, K. 1994. Role of proteasomes modified by interferon-gamma in antigen processing. J. Leukoc. Biol. 56: 571-575.
7. Tanaka, K., and M. Kasahara. 1998. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol. Rev. 163: 161-176.
8. Robek, M. D., M. L. Garcia, B. S. Boyd, and F. V. Chisari. 2007. Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus. J. Virol. 81: 483-491. (Pubitemid 46067875)
9. Wieland, S. F., R. G. Vega, R. Müller, C. F. Evans, B. Hilbush, L. G. Guidotti, J. G. Sutcliffe, P. G. Schultz, and F. V. Chisari. 2003. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J. Virol. 77: 1227-1236.
10. Khan, S., M. van den Broek, K. Schwarz, R. de Giuli, P. A. Diener, and M. Groettrup. 2001. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167: 6859-6868. (Pubitemid 33144178)
11. Griffin, T. A., D. Nandi, M. Cruz, H. J. Fehling, L. V. Kaer, J. J. Monaco, and R. A. Colbert. 1998. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J. Exp. Med. 187: 97-104.
12. Groettrup, M., S. Standera, R. Stohwasser, and P. M. Kloetzel. 1997. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. USA 94: 8970-8975.
13. Dahlmann, B., T. Ruppert, L. Kuehn, S. Merforth, and P.-M. Kloetzel. 2000. Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J. Mol. Biol. 303: 643-653.
14. Drews, O., R. Wildgruber, C. Zong, U. Sukop, M. Nissum, G. Weber, A. V. Gomes, and P. Ping. 2007. Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol. Cell. Proteomics 6: 2021-2031.
15. Cascio, P., C. Hilton, A. F. Kisselev, K. L. Rock, and A. L. Goldberg. 2001. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20: 2357-2366. (Pubitemid 32452853)
16. Kloetzel, P. M., and F. Ossendorp. 2004. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 16: 76-81.
17. Chen, W., C. C. Norbury, Y. Cho, J. W. Yewdell, and J. R. Bennink. 2001. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193: 1319-1326.
18. Caudill, C. M., K. Jayarapu, L. Elenich, J. J. Monaco, R. A. Colbert, and T. A. Griffin. 2006. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J. Immunol. 176: 4075-4082.
19. Zaiss, D. M., N. de Graaf, and A. J. Sijts. 2008. The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion. Infect. Immun. 76: 1207-1213.
20. Yewdell, J. W. 2005. The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol. Rev. 207: 8-18.
21. Nussbaum, A. K., M. P. Rodriguez-Carreno, N. Benning, J. Botten, and J. L. Whitton. 2005. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J. Immunol. 175: 1153-1160.
22. Asselin-Paturel, C., A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. Dezutter-Dambuyant, A. Vicari, A. O'Garra, C. Biron, F. Brière, and G. Trinchieri. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2: 1144-1150.
23. Macagno, A., M. Gilliet, F. Sallusto, A. Lanzavecchia, F. O. Nestle, and M. Groettrup. 1999. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 29: 4037-4042.
24. Pang, K. C., M. T. Sanders, J. J. Monaco, P. C. Doherty, S. J. Turner, and W. Chen. 2006. Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses. J. Immunol. 177: 7680-7688.
25. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1: 533-541. (Pubitemid 2156893)
26. Scherle, P. A., and W. Gerhard. 1986. Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J. Exp. Med. 164: 1114-1128.
27. Sangster, M. Y., J. M. Riberdy, M. Gonzalez, D. J. Topham, N. Baumgarth, and P. C. Doherty. 2003. An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J. Exp. Med. 198: 1011-1021.
28. Sha, Z., and R. W. Compans. 2000. Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J. Virol. 74: 4999-5005. (Pubitemid 30313838)
29. Lee, B. O., J. Rangel-Moreno, J. E. Moyron-Quiroz, L. Hartson, M. Makris, F. Sprague, F. E. Lund, and T. D. Randall. 2005. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J. Immunol. 175: 5827-5838.
30. Le Bon, A., G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardelli, and D. F. Tough. 2001. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14: 461-470. (Pubitemid 32441598)
31. Jego, G., A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234. (Pubitemid 37011337)
32. Goldberg, A. L. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899.
33. Cenci, S., and R. Sitia. 2007. Managing and exploiting stress in the antibody factory. FEBS Lett. 581: 3652-3657. (Pubitemid 47081003)
34. Cascio, P., L. Oliva, F. Cerruti, E. Mariani, E. Pasqualetto, S. Cenci, and R. Sitia. 2008. Dampening Ab responses using proteasome inhibitors following in vivo B cell activation. Eur. J. Immunol. 38: 658-667.
35. Fan, C. M., and T. Maniatis. 1991. Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway. Nature 354: 395-398.
36. Hayashi, T., and D. Faustman. 1999. NOD mice are defective in proteasome production and activation of NF-kappaB. Mol. Cell. Biol. 19: 8646-8659.
37. Runnels, H. A., W. A. Watkins, and J. J. Monaco. 2000. LMP2 expression and proteasome activity in NOD mice. Nat. Med. 6: 1064-1065, author reply 1065-1066.
38. Cai, Z. P., Z. Shen, L. Van Kaer, and L. C. Becker. 2008. Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J. 22: 4248-4257.
39. Ding, Q., S. Martin, E. Dimayuga, A. J. Bruce-Keller, and J. N. Keller. 2006. LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. Antioxid. Redox Signal. 8: 130-135.
40. Khan, M. A., H. Oubrahim, and E. R. Stadtman. 2004. Inhibition of apoptosis in acute promyelocytic leukemia cells leads to increases in levels of oxidized protein and LMP2 immunoproteasome. Proc. Natl. Acad. Sci. U.S.A. 101: 11560-11565.
41. Díaz-Hernández, M., F. Hernández, E. Martín-Aparicio, P. Gómez-Ramos, M. A. Morán, J. G. Castaño, I. Ferrer, J. Avila, and J. J. Lucas. 2003. Neuronal induction of the immunoproteasome in Huntington's disease. J. Neurosci. 23: 11653-11661. (Pubitemid 38021292)